Skip to main content
. 2022 Sep 13;14(18):4436. doi: 10.3390/cancers14184436

Table 2.

Percent change MRI variables after 3 weeks of therapy.

MRI Variable Full (n = 103) Control (n = 75) Pembro (n = 28)
pCR (n = 30) Non-pCR (n = 73) p pCR (n = 15) Non-pCR (n = 60) p pCR (n = 15) Non-pCR (n = 13) p
ADC_mean 18.9 (4.4, 23.6) 10.2 (2.6, 15.3) 0.0076 15.8 (3.1, 22.9) 10.3 (5.1, 15.8) 0.13 19.2 (8.2, 23.1) 3.5 (−2.4, 14.7) 0.041
ADC_min 28.0 (5.9, 54.7) 12.6 (−0.7, 24.6) 0.0075 23.4 (−2.7, 53.0) 14.1 (−0.8, 19.4) 0.15 29.7 (10.6, 56.5) 9.6 (−0.2, 20.8) 0.029
ADC_5 20.0 (−1.1, 32.8) 8.0 (0, 17.5) 0.0297 18.2 (−6.5, 33.5) 9.1 (−0.3, 19.4) 0.35 23.5 (4.7, 32.1) 6.1 (4.6, 10.5) 0.0799
ADC_15 17.3 (0.3, 27.6) 9.6 (2.4, 16.0) 0.039 14.6 (0.6, 26.7) 9.9 (3.3, 17.2) 0.47 22.2 (2.2, 28.3) 7.8 (1.1, 11.2) 0.040
ADC_25 17.9 (3.1, 29.7) 8.6 (2.4, 15.4) 0.014 15.7 (1.8, 23.2) 10.2 (3.6, 16.2) 0.25 23.6 (5.3, 31.4) 5.2 (0, 11.9) 0.025
ADC_50 18.0 (3.0, 23.5) 10.1 (3.2, 15.5) 0.048 13.2 (0.2, 23.8) 10.4 (3.8, 15.5) 0.34 19.5 (7.1, 22.996) 2.9 (−1.2, 14.2) 0.098
ADC_75 14.9 (1.5, 23.7) 8.5 (1.8, 15.6) 0.052 14.6 (1.1, 25.3) 8.9 (2.8, 14.9) 0.19 15.2 (5.5, 21.1) 1.8 (−3.6, 17.4) 0.196
ADC_95 15.0 (1.1, 20.4) 7.3 (0, 14.0) 0.087 18.6 (7.9, 22.6) 7.5 (1.5, 14.3) 0.027 6.01 (0.5, 16.1) 0.8 (−4.98, 12.5) 0.39
ADC_max 6.3 (−1.2, 11.8) 7.4 (−1.7, 13.8) 0.85 10.8 (1.8, 14.8) 7.5 (−2.2, 14.6) 0.53 3.8 (−5.5, 9.7) 3.8 (0.7, 9.9) 0.82
FTV −56.97 (−83.9, −19.98) −31.5 (−58.4, −3.8) 0.016 −59.9 (−82.0, −14.2,) −30.6 (−54.2, −2.7) 0.056 −47.7 (−83.4, −20) −46.3 (−64.6, −8.99) 0.34